EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Rapid Progression and Shorter Survival in Indians Affected with Probable MSA : A Prospective Cohort Study

Malligurki Raghurama Rukmani, Ravi Yadav iD, Binukumar Bhaskarapillai, Pramod Kumar Pal iD, Talakad Narasappa Sathyaprabha

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.70301 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Malligurki Raghurama Rukmani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India. Hauptthemen laut MEDLINE: Multiple System Atrophy, alpha-Synuclein. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple system atrophy (MSA) is a fatal alpha‐synucleinopathy characterized by variable combinations of parkinsonism and autonomic and cerebellar dysfunctions.

Objective

We aimed to prospectively study the natural history of probable MSA, including cardiovascular autonomic dysfunction (CAD) and serum alpha‐synuclein.

Methods

Sixty probable MSA patients (MSA‐P = 19; MSA‐C = 41) and 30 age‐and‐gender‐matched healthy controls were recruited. Disease severity (UPDRS III, UMSARS I, II, IV), CAD, and serum alpha‐synuclein (ELISA) were assessed at baseline, 6‐month (6 M‐FU), and 12‐month (12 M‐FU) follow‐ups. Survival probabilities (Kaplan–Meir analysis) and prognostic factors (Cox proportional hazards analysis) were assessed at the study's end period.

Results

Total serum alpha‐synuclein was higher in MSA patients than controls ( P < 0.001). There was severe CAD in MSA patients at baseline ( P < 0.001), which further deteriorated at 12 M‐FU ( P < 0.01). A greater proportion of MSA‐P patients had a dopaminergic benefit than MSA‐C patients ( P < 0.001). CAD had a positive correlation with serum alpha‐synuclein and disease severity. UPDRS III and UMSARS II scores were higher at follow‐ups ( P < 0.001). Disease progression was more rapid in MSA‐C patients than MSA‐P patients ( P < 0.001). The median time to one‐person support for walking and activities of daily living (ADL), wheelchair support, bedbound state, and death were 27, 48, 66, and 70 months, respectively. The probabilities of needing one‐person support and wheelchair support were lower in MSA‐P patients than MSA‐C ( P = 0.005; P = 0.03), whereas the probabilities of bedbound state and death were similar.

Conclusions

Probable MSA patients had a rapid progression, autonomic failure, and a shorter survival of 5.8 years in this Asian‐Indian cohort compared to the other MSA cohorts worldwide (9–10 years). MSA‐P patients had a better prognosis than MSA‐C. Elevated serum alpha‐synuclein and its positive correlation with CAD provide evidence for its role as a potential biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple System Atrophyalpha-SynucleinHumansFemaleMaleMiddle AgedDisease ProgressionIndiaProspective StudiesAgedSeverity of Illness IndexAdultAutonomic Nervous System Diseases

Stichwörter der Autor:innen

cardiovascular autonomic dysfunctiondisease progressionmultiple system atrophyserum alpha‐synucleinsurvival

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India.
  • Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India.
  • Department of Biostatistics, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, India.

ORCID-Profile: Ravi Yadav, Pramod Kumar Pal

Zitieren

APA

Rukmani, M. R., Yadav, R., Bhaskarapillai, B., Pal, P. K., & Sathyaprabha, T. N. (2025). Rapid Progression and Shorter Survival in Indians Affected with Probable MSA : A Prospective Cohort Study. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70301

Vancouver

Rukmani MR, Yadav R, Bhaskarapillai B, Pal PK, Sathyaprabha TN. Rapid Progression and Shorter Survival in Indians Affected with Probable MSA : A Prospective Cohort Study. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.70301

BibTeX
@article{Rukmani2025,
  author = {Rukmani, Malligurki Raghurama and Yadav, Ravi and Bhaskarapillai, Binukumar and Pal, Pramod Kumar and Sathyaprabha, Talakad Narasappa},
  title = {Rapid Progression and Shorter Survival in Indians Affected with Probable MSA : A Prospective Cohort Study},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.70301}
}
Kostenlos starten →